UPMC-Shadyside Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
UPMC-Shadyside Hospital has participated in 156 clinical trials with 86 currently active.
Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, NRG Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Pittsburgh
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC-Shadyside Hospital has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC-Shadyside Hospital has 156 clinical trials on record, with 86 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.
UPMC-Shadyside Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.